SVBI vs Lotus Pharm: monthly revenue

Monthly revenue and year-on-year change for SVBI (1786) and Lotus Pharm (1795) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ SVBI ━ Lotus Pharm

0%+226%-23%25/1026/0126/0426/0726/10

Monthly revenue history

MonthSVBIYoYLotus PharmYoY
Oct 2026NT$78.3 million+1.6%NT$2.13 billion-22.5%
Sep 2026NT$61.1 million+1.3%NT$2.77 billion+128.0%
Aug 2026NT$66.4 million-22.7%NT$2.11 billion+81.7%
Jul 2026NT$75.2 million+0.0%NT$2.49 billion+3.9%
Jun 2026NT$74.4 million+1.0%NT$3.4 billion+225.5%
May 2026NT$73.4 million+1.0%NT$2.32 billion+105.8%
Apr 2026NT$63.2 million+0.1%NT$3.09 billion+19.9%
Mar 2026NT$74.8 million+0.8%NT$4.35 billion+173.6%
Feb 2026NT$55.1 million+0.1%NT$2.24 billion+131.5%
Jan 2026NT$75.4 million+0.5%NT$2.05 billion-5.5%
Dec 2025NT$94.2 million+1.2%NT$2.44 billion+66.9%
Nov 2025NT$80.2 million-1.7%NT$1.06 billion-0.2%
Oct 2025NT$77 million-4.4%NT$2.75 billion+46.0%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16